Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Depression reported to reduce the efficacy of IFN-alpha plus ribavirin in hepatitis C

Jan. 24, 2005

Pegasys receives positive opinion in E.U. for hepatitis B

Jan. 24, 2005

Enzo Biochem receives grant to conduct study of EGS-21 for fatty liver disease

Jan. 20, 2005

First clinical data on the efficacy of peginterferon alfa-2b monotherapy in chronic hepatitis B

Jan. 18, 2005

Update on the safety and antiviral effects of Actilon in hepatitis C

Jan. 18, 2005

Phase III data on the effects of peginterferon alfa-2b plus ribavirin in HIV-HCV coinfection

Jan. 14, 2005

Dextofisopam reported effective and well tolerated in IBS

Jan. 14, 2005

Antiinfective agents claimed by GlaxoSmithKline

Jan. 13, 2005

A valopicitabine plus pegylated interferon regimen shows promise in hepatitis C

Jan. 13, 2005

Traficet-EN studied in phase II for IBD

Jan. 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.